Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pfizer Ltd. Regulatory Filings 2025

May 13, 2025

60507_rns_2025-05-13_27991ffa-cd40-4265-85ac-b28b8fe927c6.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

==> picture [100 x 41] intentionally omitted <==

Pfizer Limited The Capital, 1802/1901, Plot No. C - 70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai 400 051. Tel : +91 22 6693 2000 Fax : +91 22 2654 0274

May 13, 2025

The Corporate Relationship Dept.

BSE Limited 1[st] Floor, P.J.Towers Dalal Street, Fort Mumbai – 400 001 Scrip Code: 500680

The Listing Dept.

The National Stock Exchange of India Ltd. Exchange Plaza, 5[th] Floor, Plot No. C/1, G Block Bandra-Kurla Complex, Bandra (E) Mumbai – 400 051 Scrip Symbol: PFIZER

Dear Sirs,

Sub: Board Meeting to consider and approve the Audited Financial Results for the quarter and Financial Year ended March 31, 2025.

Ref.: Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

This is to inform that a meeting of the Board of Directors of the Company is scheduled to be held on Monday, May 19, 2025 inter alia, to consider, approve and take on record the Audited Financial Results of the Company for the quarter and Financial Year ended March 31, 2025 and to consider recommendation of dividend, if any, for the Financial Year ended March 31, 2025.

Further, pursuant to the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading), Regulations, 2015 and in accordance with “Pfizer Limited – Code of Internal Procedures and Conduct to Regulate, Monitor and Report Trading by Insiders”, the Trading Window for dealing in shares of the Company has been closed from Monday, March 31, 2025 (close of business) till 48 hours after the said Audited Financial Results are made public on May 19, 2025.

Request you to please take the above on record.

Thanking you,

Yours truly, For Pfizer Limited Prajeet Digitally signed by Prajeet Nair Nair Date: 2025.05.13 22:07:36 +05'30' Prajeet Nair Director – Corporate Services & Company Secretary

Cc: National Securities Depository Limited (NSDL) Central Depository Services (India) Limited (CDSL) KFin Technologies Limited

CIN: L24231MH1950PLC008311 Email ID: [email protected] Website: www.pfizerltd.co.in